The Immune-related Role of BRAF Mutation in Melanoma

被引：0
|
作者：
Tomei, Sara [1 ,2 ]
Civini, Sara [3 ]
Bedognetti, Davide [1 ,2 ]
De Giorgi, Valeria [1 ,2 ]
Reinboth, Jennifer [1 ,2 ]
Ascierto, Maria Libera [1 ,2 ]
Liu, Qiuzhen [1 ,2 ]
Uccellini, Lorenzo [1 ,2 ]
Wang, Ena [1 ,2 ]
Marincola, Francesco M. [1 ,2 ]
机构：
[1] NIH, IDIS, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA
[2] NIH, Trans NIH Ctr Human Immunol CHI, Bethesda, MD 20892 USA
[3] NIH, CPS, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2012年 / 35卷 / 09期
关键词：
Melanoma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：788 / 789
页数：2
相关论文
共 50 条
  • [1] The immune-related role of BRAF in melanoma
    Tomei, Sara
    Bedognetti, Davide
    De Giorgi, Valeria
    Sommariva, Michele
    Civini, Sara
    Reinboth, Jennifer
    Al Hashmi, Muna
    Ascierto, Maria Libera
    Liu, Qiuzhen
    Ayotte, Ben D.
    Worschech, Andrea
    Uccellini, Lorenzo
    Ascierto, Paolo A.
    Stroncek, David
    Palmieri, Giuseppe
    Chouchane, Lotfi
    Wang, Ena
    Marincola, Francesco M.
    MOLECULAR ONCOLOGY, 2015, 9 (01) : 93 - 104
  • [2] The immune-related role of BRAF in melanoma
    Sara Tomei
    Davide Bedognetti
    Valeria De Giorgi
    Michele Sommariva
    Sara Civini
    Jennifer Reinboth
    Muna Al Hashmi
    Maria Libera Ascierto
    Qiuzhen Liu
    Ben D Ayotte
    Andrea Worschech
    Lorenzo Uccellini
    Paolo A Ascierto
    David Stroncek
    Giuseppe Palmieri
    Lotfi Chouchane
    Ena Wang
    Francesco M Marincola
    Journal of Translational Medicine, 13 (Suppl 1)
  • [3] BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma
    Mann, Graham J.
    Pupo, Gulietta M.
    Campain, Anna E.
    Carter, Candace D.
    Schramm, Sarah-Jane
    Pianova, Svetlana
    Gerega, Sebastien K.
    De Silva, Chitra
    Lai, Kenneth
    Wilmott, James S.
    Synnott, Maria
    Hersey, Peter
    Kefford, Richard F.
    Thompson, John F.
    Yang, Yee Hwa
    Scolyer, Richard A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (02) : 509 - 517
  • [4] The immune-related role of beta-2-microglobulin in melanoma
    Wang, Chuqiao
    Wang, Zeqi
    Yao, Tengteng
    Zhou, Jibo
    Wang, Zhaoyang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Exploration of the Immune-Related Signatures and Immune Infiltration Analysis in Melanoma
    Li, Ai-lan
    Zhu, Yong-mei
    Gao, Lai-qiang
    Wei, Shu-yue
    Wang, Ming-tao
    Ma, Qiang
    Zheng, You-you
    Li, Jian-hua
    Wang, Qing-feng
    ANALYTICAL CELLULAR PATHOLOGY, 2021, 2021
  • [6] The role of BRAF V600 mutation in melanoma
    Paolo A Ascierto
    John M Kirkwood
    Jean-Jacques Grob
    Ester Simeone
    Antonio M Grimaldi
    Michele Maio
    Giuseppe Palmieri
    Alessandro Testori
    Francesco M Marincola
    Nicola Mozzillo
    Journal of Translational Medicine, 10
  • [7] The role of BRAF V600 mutation in melanoma
    Ascierto, Paolo A.
    Kirkwood, John M.
    Grob, Jean-Jacques
    Simeone, Ester
    Grimaldi, Antonio M.
    Maio, Michele
    Palmieri, Giuseppe
    Testori, Alessandro
    Marincola, Francesco M.
    Mozzillo, Nicola
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [8] Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient
    Boutros, Andrea
    Schiavi, Chiara
    Cecchi, Federica
    Spagnolo, Francesco
    Guadagno, Antonio
    Tanda, Enrica Teresa
    Giusti, Francesca
    Murdaca, Giuseppe
    Queirolo, Paola
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [9] Data-driven analysis to identify prognostic immune-related biomarkers in BRAF mutated cutaneous melanoma microenvironment
    Huang, Biao
    Su, Wenxing
    Yu, Daojiang
    FRONTIERS IN GENETICS, 2022, 13
  • [10] Pembrolizumab in a BRAF-mutant metastatic melanoma patient following a severe immune-related adverse event with ipilimumab
    Aya, Francisco
    Fernandez-Martinez, Aranzazu
    Gaba, Lydia
    Victoria, Ivan
    Tosca, Monica
    Carrera, Cristina
    Prat, Aleix
    Arance, Ana
    IMMUNOTHERAPY, 2016, 8 (06) : 687 - 692
12345